These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 5809151)

  • 1. [General therapy of arteriosclerosis].
    Siedek H
    Wien Klin Wochenschr; 1969 Jun; 81(25):464-6. PubMed ID: 5809151
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of arteriosclerosis].
    Emmrich R
    Z Gesamte Inn Med; 1968 Jan; 23(2):28-32. PubMed ID: 4177784
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of atherosclerosis].
    Negoiţă CI
    Med Interna (Bucur); 1971 Mar; 23(3):325-33. PubMed ID: 5574929
    [No Abstract]   [Full Text] [Related]  

  • 4. [Problems of arteriosclerosis epidemiology. Analysis of risk factors with a view to a possible therapy].
    Prof Aiuto G
    Minerva Med; 1976 Dec; 67(62):4059-118. PubMed ID: 1018807
    [No Abstract]   [Full Text] [Related]  

  • 5. [Current position in the treatment of arteriosclerosis].
    Emmrich R
    Z Alternsforsch; 1974; 28(1):31-8. PubMed ID: 4409098
    [No Abstract]   [Full Text] [Related]  

  • 6. [The treatment of blood circulation disorders with an adenosine-theophylline sodium nicotinate combination].
    Hüdepohl M; Bockelmann R
    Med Klin; 1966 Feb; 61(5):184-6. PubMed ID: 5982907
    [No Abstract]   [Full Text] [Related]  

  • 7. [The present status of treatment of arteriosclerosis].
    Apostoloff E
    Dtsch Gesundheitsw; 1967 Feb; 22(8):337-47. PubMed ID: 4869957
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experience in the treatment of arteriosclerotic circulatory disorders using Seniosan in the general practice].
    Rölke H
    Med Welt; 1969 Mar; 13():746-50. PubMed ID: 4185050
    [No Abstract]   [Full Text] [Related]  

  • 9. [Experimental atheroma in rabbits: their protection by various lipolytic agents].
    Perrin A; Loire R; Couchat MC; Bourdillon MC; Gras J
    Rev Lyon Med; 1968 Nov; 17(17):727-40. PubMed ID: 5712165
    [No Abstract]   [Full Text] [Related]  

  • 10. [Control of fat clearance insufficiency in hyperlipemic atherosclerosis].
    Zeller W; Christ F
    Med Klin; 1966 Jan; 61(4):136-9. PubMed ID: 5983158
    [No Abstract]   [Full Text] [Related]  

  • 11. [Arteriosclerosis and nicotinic acid therapy. 4. Nicotinic acid therapy].
    Ribom U
    Lakartidningen; 1971 Apr; 68(15):1750-2. PubMed ID: 5577246
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug therapy in geriatrics].
    von Raffler E
    Z Allgemeinmed; 1972 Sep; 48(25):1142-8. PubMed ID: 5083374
    [No Abstract]   [Full Text] [Related]  

  • 13. [Arteriosclerosis--nicotinic acid therapy. 6. Treatment of hyperlipemia].
    Orö L
    Lakartidningen; 1971 Apr; 68(15):1758-62. PubMed ID: 5577248
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on the therapy of hyperlipemic athersclerosis and liver epithelial fatty degeneration with beta-pyridylcarbinol].
    Zeller W; Schön H; Wüst H; Anders U; Ammon HP
    Klin Wochenschr; 1966 Sep; 44(17):1022-8. PubMed ID: 5993594
    [No Abstract]   [Full Text] [Related]  

  • 15. [Arteriosclerosis].
    Anschütz F
    Z Allgemeinmed; 1969 Nov; 45(31):1461-70. PubMed ID: 4903599
    [No Abstract]   [Full Text] [Related]  

  • 16. [New aspects of the therapy of arteriosclerosis].
    Avogaro P; Capri C; Cazzolato G
    Recenti Prog Med; 1971 Nov; 51(5):455-70. PubMed ID: 5172398
    [No Abstract]   [Full Text] [Related]  

  • 17. [Prophylactic and therapeutic perspectives in arteriosclerosis].
    Masini V; Concina B
    Policlinico Prat; 1967 Jul; 74(27):901-24. PubMed ID: 4885120
    [No Abstract]   [Full Text] [Related]  

  • 18. [Biochemical changes in atherosclerosis: current concepts and experimental applications].
    Porcellati G; Valcavi U; Gaiti A
    Minerva Med; 1971 Sep; 62(72):3414-30. PubMed ID: 4255471
    [No Abstract]   [Full Text] [Related]  

  • 19. [Angiotics. 48. I. Hypertensive agents. II. Hypotensive agents. 3. Vasodilator agents. IV. Agents for the treatment of lipid metabolism disorders].
    Selchau M
    Pharm Prax; 1970; 9():200-16 contd. PubMed ID: 4320846
    [No Abstract]   [Full Text] [Related]  

  • 20. [Medical treatment of hyperlipemia. Indications and modern preparations].
    Frey H
    Tidsskr Nor Laegeforen; 1968 Jan; 88(2):6-8. PubMed ID: 5663311
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.